Cleared Traditional

K260324 - Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) Planning (FDA 510(k) Clearance)

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K260324 · Canon Medical Informatics, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2026
Decision
112d
Days
Class 2
Risk

K260324 is an FDA 510(k) clearance for the Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) Planning. Classified as Automated Radiological Image Processing Software within the QIH classification (a category dominated by AI-based automated radiology processing systems), Class II - Special Controls.

Submitted by Canon Medical Informatics, Inc. (Minnetonka, US). The FDA issued a Cleared decision on May 22, 2026 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Canon Medical Informatics, Inc. devices

Submission Details

510(k) Number K260324 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 30, 2026
Decision Date May 22, 2026
Days to Decision 112 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
5d slower than avg
Panel avg: 107d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QIH Automated Radiological Image Processing Software
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
Definition To Provide Automated Radiological Image Processing And Analysis Tools. Software Implementing Artificial Intelligence Including Nonadaptive Machine Learning Algorithms Trained With Clinical And/or Artificial Data. In These Devices, The Algorithm Training Data Typically Impacts Device Performance. Adaptive Ai Algorithms Are Not Within Scope Of This Product Code.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - QIH Automated Radiological Image Processing Software

All 295
Devices cleared under the same product code (QIH) and FDA review panel - the closest regulatory comparables to K260324.
OrthoGrid Hip AI® 4.0
K260077 · OrthoGrid Systems, Inc. · May 2026
ANDI 2.2
K261405 · Imeka Solutions, Inc. · May 2026
BAC
K254131 · DeepHealth, Inc. · May 2026
MSK Go
K260234 · Smart Alfa Teknoloji San. Ve Tic. A.S. · May 2026
Neurophet SCALE PET
K252563 · Neurophet., Inc. · May 2026
SubtleHD-CT (1.x)
K254120 · Subtle Medical, Inc. · May 2026